EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
+6.62%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$535M
AUM Growth
+$535M
(+4.1%)
Cap. Flow
-$4.43M
Cap. Flow
% of AUM
-0.83%
Top 10 Holdings %
Top 10 Hldgs %
63.96%
Holding
32
New
5
Increased
3
Reduced
10
Closed
5
Top Buys
| 1 |
Danaher
DHR
|
$41.3M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
$19.9M |
| 3 |
Transmedics
TMDX
|
$19.5M |
| 4 |
United Therapeutics
UTHR
|
$8.74M |
| 5 |
Icon
ICLR
|
$7.58M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$35.4M |
| 2 |
Intuitive Surgical
ISRG
|
$19.1M |
| 3 |
Inspire Medical Systems
INSP
|
$9.32M |
| 4 |
Natera
NTRA
|
$9.21M |
| 5 |
DexCom
DXCM
|
$8.89M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
IQVIA
IQV
$32.4B
| $49.3M | 9.22% |
219,495
-7,000
| -3% | -$1.57M |
|
|
2
Icon
ICLR
$13.8B
| $46.6M | 8.71% |
186,200
+30,300
| +19% | +$7.58M |
|
|
3
Danaher
DHR
$147B
| $41.3M | 7.72% |
+172,085
| New | +$41.3M |
|
|
4
United Therapeutics
UTHR
$13.8B
| $37.7M | 7.05% |
170,838
+39,600
| +30% | +$8.74M |
|
5
Illumina
ILMN
$15.8B
| $31M | 5.79% |
165,300
-42,172
| -20% | -$7.91M |
|
|
6
Intuitive Surgical
ISRG
$170B
| $29.8M | 5.58% |
87,290
-55,800
| -39% | -$19.1M |
|
|
7
Natera
NTRA
$23.1B
| $29M | 5.42% |
595,694
-189,200
| -24% | -$9.21M |
|
8
Outset Medical
OM
$247M
| $26.3M | 4.91% |
1,200,385
| – | – |
|
9
Alnylam Pharmaceuticals
ALNY
$58.5B
| $26M | 4.86% |
136,756
| – | – |
|
10
argenx
ARGX
$43.6B
| $25.1M | 4.69% |
64,400
| – | – |
|
|
11
Inspire Medical Systems
INSP
$2.77B
| $23.6M | 4.42% |
72,843
-28,700
| -28% | -$9.32M |
|
12
Lantheus
LNTH
$3.73B
| $21.2M | 3.97% |
253,200
-31,600
| -11% | -$2.65M |
|
|
13
DexCom
DXCM
$29.5B
| $20.9M | 3.9% |
162,400
-69,200
| -30% | -$8.89M |
|
|
CTLT
14
DELISTED
CATALENT, INC.
CTLT
| $19.9M | 3.73% |
+459,621
| New | +$19.9M |
|
|
15
Transmedics
TMDX
$3.92B
| $19.5M | 3.64% |
+232,032
| New | +$19.5M |
|
16
Guardant Health
GH
$8.41B
| $15.9M | 2.98% |
445,161
-151,400
| -25% | -$5.42M |
|
17
Procept Biorobotics
PRCT
$2.23B
| $11.9M | 2.23% |
337,218
+53,000
| +19% | +$1.87M |
|
18
Sarepta Therapeutics
SRPT
$1.78B
| $11.1M | 2.08% |
97,340
-41,300
| -30% | -$4.73M |
|
19
Adaptive Biotechnologies
ADPT
$2.01B
| $8.15M | 1.52% |
1,214,860
| – | – |
|
20
4D Molecular Therapeutics
FDMT
$288M
| $7.91M | 1.48% |
437,911
| – | – |
|
21
Tandem Diabetes Care
TNDM
$845M
| $7.86M | 1.47% |
320,325
-105,200
| -25% | -$2.58M |
|
22
Agios Pharmaceuticals
AGIO
$2.19B
| $7.58M | 1.42% |
267,630
| – | – |
|
|
CANO
23
DELISTED
Cano Health, Inc.
CANO
| $5.96M | 1.12% |
4,290,901
| – | – |
|
|
FUSN
24
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $3.18M | 0.59% |
+680,370
| New | +$3.18M |
|
25
American Well
AMWL
$111M
| $2.93M | 0.55% |
1,395,039
| – | – |
|